13659-23-9

Basic information

• Product Name: 2-Bromo-5-chlorophenol
• Synonyms: Phenol,2-broMo-5-chloro-
• CAS NO: 13659-23-9
• Molecular Formula: C₆H₄BrClO
• Molecular Weight: 207.46
• Product Categories: Heterocycles
• Mol File: 13659-23-9.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 222.158 °C at 760 mmHg
• Flash Point: 88.159 °C
• Appearance: /
• Density: 1.788 g/cm³
• Vapor Pressure: 0.069mmHg at 25°C
• Refractive Index: 1.619
• Storage Temp.: Keep Cold
• PKA: 7.47±0.10(Predicted)
• CAS DataBase Reference: 2-Bromo-5-chlorophenol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Bromo-5-chlorophenol(13659-23-9)
• EPA Substance Registry System: 2-Bromo-5-chlorophenol(13659-23-9)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 13659-23-9(Hazardous Substances Data)

Usage

Chemical Properties

Pale yellow crystalline powder

InChI:InChI=1/C6H4BrClO/c7-5-2-1-4(8)3-6(5)9/h1-3,9H

Upstream product

• 823-57-4 2-bromo-5-chloroaniline 
• 108-43-0 3-monochlorophenol 
• 255051-38-8 4-(4-chloro-2-(R,S)-methylsulfinylphenyl)piperidine 
• 16817-43-9 5-Bromo-2-chloroanisole 
• 174913-09-8 2-bromo-5-chloroanisole 
• 1193-72-2 1-bromo-2,4-dichlorobenzene 
• 124-41-4 sodium methylate 
• 41513-04-6 2-chloro-5-bromonitrobenzene 

Downstream Products

• 1056942-37-0 1-bromo-4-chloro-2-(difluoromethoxy)benzene 
• 690261-59-7 1-bromo-4-chloro-2-[(phenylmethyl)-oxy]-benzene 
• 1150315-94-8 4-{[(2-bromo-4-chlorophenyl)oxy]methyl}-1-(phenylmethyl)-1,2,3,6-tetrahydropyridine 
• 174913-09-8 2-bromo-5-chloroanisole 
• 3380-34-5 triclosan 
• 1562338-42-4 5-(1H-pyrazol-4-yl)-2-(6-((2,2,6,6-tetramethylpiperidin-4-yl)oxy)pyridazin-3-yl)phenol 

Relevant articles and documents

Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners

The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.

ANTIDIABETIC BICYCLIC COMPOUNDS

Tricyclic compounds containing a cyclopropyl carboxylic acid or carboxylic acid derivative (e.g. amide) fused to a bicyclic ring, including pharmaceutically acceptable salts and prodrugs thereof, are agonists of G-protein coupled receptor 40 (GPR40) and are useful as therapeutic compounds, particularly in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.

N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS

A compound of formula I wherein: R is alkyl; R1 is optionally substituted phenyl 2-oxo-tetrahydro-1(2H)-pyrimidinyl, or 2-oxo-1-piperidinyl; R2 is hydrogen, alkoxy, alkanoyloxy, alkoxycarbonyl, alkanoylamino, acyl, alkyl, carbamoyl, N-alkylcarbamoyl, N,N-dialkylcarbamoyl where the alkyl groups are the same or different, hydroxy, thioacyl, thiocarbamoyl, N-alkylthiocarbamoyl, or N,N-dialkylthiocarbamoyl where the alkyl groups are the same or different. X1 and X2 are independently hydrogen or halo, provided that at least one of X1 or X2 is halo; and R3, R4, R5 and R6 are independently hydrogen, cyano, nitro, trifluoromethoxy, trifluoromethyl, or alkylsulfonyl are antagonists of at least one tachykinin receptor and are useful in the treatment of depression, anxiety, asthma, pain, inflammation, urinary incontinence and other disease conditions. Process for their preparation are described, as are compositions containing them and their use.